ESTRADIOL
| Brand name | MINIVELLE |
|---|---|
| Active ingredient | ESTRADIOL |
| Strength | 0.05MG/24HR |
| Dosage form | FILM, EXTENDED RELEASE |
| Route | TRANSDERMAL |
| Modality | Small molecule |
| FDA approval | October 2012 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8231906 | July 2030 | substance, product |
| 9730900 | July 2028 | use U-2086 |
| 9833419 | July 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.